FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/06/034015 [Registered on: 05/06/2021] Trial Registered Prospectively
Last Modified On: 08/11/2021
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A Clinical Study with Molnupiravir Capsules 800mg in COVID-19 Patients with Mild symptoms. 
Scientific Title of Study   A Multi-Centre, Prospective, Open Label, Parallel, Randomized, Clinical Trial to Assess the Efficacy And Safety Of Molnupiravir 800 Mg Capsules And Standard of Care (SoC) Compared To Standard of Care (SoC) Only In Mild Patients With Polymerase Chain Reaction (PCR) Confirmed COVID-19.  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NV-05-1154-2021, Version No 1.0 Dated 14.05.2021  DCGI 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Vimla Dsouza 
Designation  Associate Director - Clinical Operation  
Affiliation  Arcolab Pvt Ltd  
Address  19/2, SKR Towers, 15th Cross Rd, Dollar Layout, 4th Phase, J. P. Nagar, Bengaluru
Bengaluru
Bangalore
KARNATAKA
560078
India 
Phone  09844224041  
Fax    
Email  Vimla.Dsouza@arcolab.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Vimla Dsouza 
Designation  Associate Director - Clinical Operation  
Affiliation  Arcolab Pvt Ltd 
Address  19/2, SKR Towers, 15th Cross Rd, Dollar Layout, 4th Phase, J. P. Nagar, Bengaluru

Bangalore
KARNATAKA
560078
India 
Phone  9844224041  
Fax    
Email  Vimla.Dsouza@arcolab.com  
 
Details of Contact Person
Public Query
 
Name  Dr Vimla Dsouza 
Designation  Associate Director - Clinical Operation  
Affiliation  Arcolab Pvt Ltd 
Address  19/2, SKR Towers, 15th Cross Rd, Dollar Layout, 4th Phase, J. P. Nagar, Bengaluru

Bangalore
KARNATAKA
560078
India 
Phone  9844224041  
Fax    
Email  Vimla.Dsouza@arcolab.com  
 
Source of Monetary or Material Support  
Strides Pharma Science Limited  
 
Primary Sponsor  
Name  Strides Pharma Science Limited  
Address  Strides House, Bilekahalli, Bannerghatta Road Bengaluru – 560076 
Type of Sponsor  Pharmaceutical industry-Global 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study
Modification(s)  
No of Sites = 25  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Rajashree Khot  All India Institute of Medical Science  Room no 239, Dept of medicine 2nd Floor, OPD. Building, All India Institute of Medical Science, MIHAN, Sumthana, Nagpur-441108, Maharashtra, India
Nagpur
MAHARASHTRA 
9823134598

rajashreekhot.s.khot@gmail.com 
Dr Aman Khanna  Aman Hospital and Research Cente  Room # 01, Ground Floor-Aman Hospital and Research Center-15, Shashwat, Opp. E.S.I Hospital, Gotri Road, Vadodara-390021
Vadodara
GUJARAT 
9904402122

amankhanna1974@gamil.com 
Dr Dipu T S  Amrita Institute of Medical Sciences  Amrita Institute of Medical Sciences, Ponekkara, Eapally, Kochi-682041
Ernakulam
KERALA 
09746106288

diputsmck@gmail.com 
Dr Yateesh J  BGS Global Institute of medical sciences and Hospital  Intensivist & HOD ICU, Assistant Professor, Room no 402, 4th floor, Department of General medicine, BGS Global Institute of medical sciences and Hospital, No.67, BGS Health and Education city, Uttarahalli Main road, Kengeri, Bengaluru
Bangalore Rural
KARNATAKA 
09741333320

Yateeshjbgsgims@gmail.com 
DrShibu Raj PS  Dr.SM CSI Medical College Hospital  Dr.SM CSI Medical College HospitalParassala Vellarada Rd, Karakonam, Trivandrum Kerala 695504
Thiruvananthapuram
KERALA 
09885714189

drshiburajps21@gmail.com 
Dr Meenakshi shah  GMERS Medical College and General Hospital  Room # NA, Department of medicine 7th Floor, GMERS Medical College and General Hospital Gotri, Gotri Road, Old TB Campus, Vadodara- 390021, Gujarat India.
Vadodara
GUJARAT 
9558275888

drmeenakshi30@yahoo.com 
Dr Vinoth Kumar  GOVERNMENT CHENGALPATTU MEDICAL COLLEGE & HOSPITAL  Room number 35, Senior Resident, Department of Chest and Tuberculosis, Chengalpattu Medical College and Hospital,No.1 G.S.T.Road,Chengalpattu-603001.
Kancheepuram
TAMIL NADU 
9962347572

mbbs.vinoth@gmail.com 
Dr Meenakshi Bhattacharya  Government Medical College  Dept of medicine 2nd Floor,Room # NA, Government Medical College, Panchakki road, Aurangabad- 431001, Maharashtra, India.
Aurangabad
MAHARASHTRA 
9922931527

mabhattacharya@gmail.com 
Dr Deepti Chand  Government Medical College and Hospital  Room # NA, Department of Research room, 2nd Floor, Near Ward 33, Government Medical College and Hospital, Medical College Square Road, Nagpur-440003, Maharashtra, India.
Nagpur
MAHARASHTRA 
9823257601

dachand.ngp@gmail.com 
Dr Sunil Naik  Govt. Medical College & Govt. General Hospital (Old RIMSGGH)  OPD No 13, 1st floor, Dept of general medicine, Govt medical college & general hospital srikakulam-532001
Srikakulam
ANDHRA PRADESH 
9440828299

rimsresearch@gmail.com 
Dr Kanugula Sudheer   Great Eastern Medical School and Hospital  Department of General Medicine, Room No NA, Great Eastern Medical School and Hospital, Ragolu,Srikakulam-532484,Andhra Pradesh, India
Srikakulam
ANDHRA PRADESH 
9666123122

drksudheerresearch@gmail.com 
Dr Somanath Dash  GSL Medical college  Department of Pulmonology, Room no -NA GSL Medical college, Lakshmi Puram, Rajahmundry, Andhra Pradesh-533296
East Godavari
ANDHRA PRADESH 
9490875703

drsomanathdashresearch@gmail.com 
Dr Pearlsy Grace Rajan  Hindu Mission Hospital  Room number 42, Dept of General Medicine, Ground floor, Hindu mission hospital, #103, GST road, West Tambaram Chennai -600045
Chennai
TAMIL NADU 
9566005007

pearlsyrajan@gmail.com 
Dr Radha Munje  Indira Gandhi Government Medical College and Hospital  Room # NA, Ground Floor, Dept of respiratory medicine Indira Gandhi Government Medical College and Hospital, C. A Road Nagpur- 440018, Maharashtra, India.
Nagpur
MAHARASHTRA 
9422147752

radhamunje@yahoo.com 
Dr Mohammad shameem  Jawaharlal Nehru Medical College   Room No 1, Dept of PB and Respiratory diseases, Ground Floor, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh 202002, Uttar Pradesh, India.
Aligarh
UTTAR PRADESH 
9412731835

mshameem@myamu.ac.in 
Dr Jigar Modia  Jupiter Hospital  Room no 3, Dept of General Medicine, Jupiter Hospitals Sunpharma atladra road,Opp.ICAI Bhavan,atladra, Vadodara, Gujarat, 390012
Vadodara
GUJARAT 
99913041639

drjigarmodianm@gmail.com 
Dr Sundar raju  King George Hospital  Room No 2, Dept of General Medicine, King George Hospital, Rsjendraprasad Ward,Maharanipeta,Visakhapatnam-30002,Andhrapradesh,India.
Visakhapatnam
ANDHRA PRADESH 
9573606609

drysundarrajuresearch@gmail.com 
Dr Jayaprakash Appajigol  KLEs Dr. Prabhakar Kore Hospital and Medical Research Centre  Room no 11, Departmental of General Medicine,Ground floor, KLEs Dr. Prabhakar Kore Hospital and Medical Research Centre, Nehru Nagar, Belagavi - 590010, Karnataka, India
Belgaum
KARNATAKA 
9844595659

jayaprakashappajigol@gmail.com 
Dr Mohammad Mirvaz Zulfikar  Malabar Medical College Hospital and Research Centre  Malabar Medical College Hospital and Research Centre, P.O.Modakkallur, Atholi, Kozhikode- 673623,Kerala
Kozhikode
KERALA 
04962701800

mohammedmzulfikar@gmail.com 
Dr Sagar Sudhir Mandlik  Navsanjeevani Hospital Raghukul sankul  Room No. 2, Critical care unit, Floor no  2, Vakratunda Hospital Pvt Ltd, Near Bandhuraj Palace, Mumbai Agra Highway, Pathardi Phara, Nashik -422010
Nashik
MAHARASHTRA 
9225343885

sagarmandlik007@yahoo.com 
Dr Sumer Choudhary  NKP Salve Institute of Medical Sciences and Research Centre and Lata Mangeshkar Hospital  Room # NA,3rd Floor, Dept of respiratory medicine & plastic surgery, NKP Salve Institute of Medical Sciences and Research Centre and Lata  Mangeshkar  Hospital, Digdoh Hills, Hingna Road, Nagpur- 440019, Maharashtra, India.
Nagpur
MAHARASHTRA 
9822267975

drsumerchaudhary91@gmail.com 
Dr Vivek G  Rajarajeswari Medical College and Hospital(RRMCH)   Room no 5, Dept of Pulmonary medicine, Rajarajeswari Medical College and Hospital ,Ground Floor,202, Kambipura, Mysore Road, Bangalore – 560074, Karnataka
Bangalore Rural
KARNATAKA 
9739701000

vivek.g27@gmail.com 
Dr Yogesh Sharma  Rajiv Gandhi Medical College and Chhatrapati Shivaji Maharaj Hospital  Room # NA, Dept of General medicine 2nd Floor, Rajiv Gandhi Medical College and Chhatrapati Shivaji Maharaj Hospital, Thane Belapur Road, Kalwa, Thane-400605, Maharashtra, India
Thane
MAHARASHTRA 
9820192129

dryogeshsharmamd@yahoo.com 
Dr B K Gupta   S.P. Medical College and A.G. of Hospitals  HOD room, Room # NA, Near ICU, Dept of medicine Research Cell, Haldi Ram Mool Chand,B-block,PBM hospital campus,SP Medical College and A.G.Hospitals, Bikaner-Rajasthan-India. 334003
Bikaner
RAJASTHAN 
9829176143

bkgbkn@rediffmail.com 
Dr Sandeep Jain  Tagore Hospital And Research Institute  Room # NA, Dept of general medicine Ground Floor, Tagore Hospital and Research Institute, Tagore Lane, Sector-7, Shipra Path, Madhyam Marg, Mansarovar, Jaipur, Rajasthan- 302020, India
Jaipur
RAJASTHAN 
9414069583

drsandeeprjain@yahoo.co.in 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 25  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE RAJARAJESWARI MEDICAL COLLEGE AND HOSPITAL NO. 202, KAMBIPURA, MYSORE ROAD, BENGALURU, KARNATAKA - 560074 INDIA  Approved 
ANAND INSTITUTIONAL ETHICS COMMITTEE, ANAND MULTISPECIALTY HOSPITAL, VADODARA B TOWER SUNDARVAN COMPLEX, BESIDE IOCL PETROL PUMP NEAR GORWA ITI, VADODARA, GUJARAT - 390016 INDIA  Approved 
ETHICS COMMITTEE, S.P. MEDICAL COLLEGE & A.G. HOSPITALS, HRMC CARDIOVASC ULA R SCIENCES & RESEARCH CENTER, BIKANER, RAJASTHAN - 334003, INDIA  Approved 
Human Ethics Committee Dr. SMCSI Medical College Karakonam Thiruvananthapuram Thiruvananthapuram Thiruvananthapuram Kerala - 695504 India  Approved 
IEC KING GEORGE HOSPITAL, KINGGEORGEHOSPITA, MAHARANIPET, COLLECTOROFFICEJUNCTION VISAKHAPATNAM, ANDHRA PRADESH - 530002 INDIA  Approved 
INSTITUTIONAL CLINICAL ETHICS COMMITTEE, RGMC AND CHATRAPATI SHIVAJI MAHARAJ HOSPITAL, THANE-BELAPUR RD, KALWA, THANE-400605, MAHARASHTRA - 400605 INDIA  Submittted/Under Review 
INSTITUTIONAL ETHICAL COMMITTEE, CHENGALPATTU MEDICAL COLLEGE, GST ROAD, KANCHIPURAM TAMIL NADU - 603001 INDIA  Approved 
Institutional Ethics Committee Amrita Institute of Medical Sciences AIMS-Ponekkara Kochi Edappally Ernakulam Kerala - 682041 India  Approved 
INSTITUTIONAL ETHICS COMMITTEE AMAN HOSPITAL AND RESEARCH CENTRE 15 SHASHWAT, OPP, E.S.I HOSPITAL SARABHAI, GOTRI ROAD VADODARA GUJARAT - 390021 INDIA  Approved 
INSTITUTIONAL ETHICS COMMITTEE FOR CLINICAL TRIAL, ALL INDIA INSTITUTE OF MEDICAL SCIENCES, PLOT NO 2, SECTOR 20 1ST FLOOR, OPD BUILDING, MIHAN, NAGPUR, MAHARASHTRA - 441108 INDIA  Submittted/Under Review 
Institutional Ethics Committee Malabar Medical College Hospital,Modakkallur Atholi Kozhikode Kozhikode Kerala - 673323 India  Approved 
INSTITUTIONAL ETHICS COMMITTEE, BGS GLOBAL INSTITUTE OF MEDICAL SCIENCES, NO 67, BGS HEALTH AND EDUCATION CITY, UTTARAHALLI ROAD, KENGERI, BENGALURU, KARNATAKA – 560060, INDIA  Approved 
INSTITUTIONAL ETHICS COMMITTEE, GEMS, GREAT EASTERN MEDICAL SCHOOL AND HOSPITAL, RAGOLU SRIKAKULAM SRIKAKULAM, ANDHRA PRADESH - 532484 INDIA  Approved 
INSTITUTIONAL ETHICS COMMITTEE, GOVERNMENT MEDICAL COLLEGE, DEPARTMENT OF PHARMACOLOGY, AURANGABAD, MAHARASHTRA - 431001 INDIA  Approved 
INSTITUTIONAL ETHICS COMMITTEE, GOVT. MEDICAL COLLEGE AND GOVT. GENERAL HOSPITAL, BALAGA, SRIKAKULAM, ANDHRA PRADESH - 532001 INDIA  Approved 
INSTITUTIONAL ETHICS COMMITTEE, GSLM CGH, GSL MEDICAL COLLEGE HOSPITAL, 6-265, LAKSHMIPURAM NH-16,RAJANAGARAM, RAJAHMUNDRY, ANDHRA PRADESH - 533296 INDIA  Approved 
INSTITUTIONAL ETHICS COMMITTEE, HINDU MISSION HOSPITAL, NO 103 GST ROAD , WEST TAMBARAM CHENNAI, KANCHIPURAM, TAMIL NADU - 600045 INDIA  Approved 
INSTITUTIONAL ETHICS COMMITTEE, INDIRA GANDHI GOVT. MEDICAL COLLEGE , DEPT. OF PHARMACOLOGY, CENTRAL AVENUE ROAD, NEAR MAIN RAILWAY STATION, NAGPUR, MAHARASHTRA- 440018 INDIA  Submittted/Under Review 
INSTITUTIONAL ETHICS COMMITTEE, JAWAHARLAL NEHRU MEDICAL COLLEGE AND HOSPITAL, ALIGARH MUSLIM UNIVERSITY, CIVIL LINE KOIL, ALIGARH, UTTAR PRADESH - 202002 INDIA  Approved 
INSTITUTIONAL ETHICS COMMITTEE, KLE UNIVERSITY KLE DR.PK HOSPITAL AND MRC, NEHRU NAGAR, BELAGAVI, KARNATAKA - 590010 INDIA  Approved 
INSTITUTIONAL ETHICS COMMITTEE, NKP SALVE INSTITUTE OF MEDICAL SCIENCES, DIGDOH HILLS, HINGNA ROAD NAGPUR MAHARASHTRA - 440019 INDIA  Approved 
INSTITUTIONAL HUMAN ETHICS COMMITTEE, GMERS MEDICAL COLLEGE AND HOSPITAL, OLD TB HOSPITAL CAMPUS, GOTRI, VADODARA, GUJARAT - 390021 INDIA  Approved 
MARUDHAR HOSPITAL ETHICS COMMITTEE, MARUDHAR HOSPITAL, A-93-99, SINGH BHOOMI, KHATIPURA ROAD JAIPUR, RAJASTHAN - 302012 INDIA  Submittted/Under Review 
NAVSANJEEVANI HOSPITAL ETHICS COMMITTEE, NAVSANJEEVANI HOSPITAL, PLOT NO. 8, MOTKARI NAGAR, TIDKE COLONY, MUMBAI NAKA, NASHIK, MAHARASHTRA - 422002, INDIA  Approved 
TAGORE HOSPITAL ETHICS COMMITTEE, TAGORE HOSPITAL AND RESEARCH INSTITUTE, TAGORE LANE, SECTOR-7, SHIPRA PATH, MADHYAM MARG, MANSAROVAR, JAIPUR, RAJASTHAN - 302020 INDIA  Submittted/Under Review 
 
Regulatory Clearance Status from DCGI  
Status 
Approved/Obtained 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: B972||Coronavirus as the cause of diseases classified elsewhere,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Molnupiravir 800 mg capsules   Molnupiravir 800 mg (4 capsules of 200 mg or 2 capsules of 400 mg) (BID) + Standard of care. Patients will be instructed to take Molnupiravir 800 mg (4 x 200 mg or 2 x 400 mg) capsules every 12 hours, for 5 days-10 doses total) orally one hour before food intake with a glass of water. 
Comparator Agent  Standard of Care  The standard of care will be as per physician recommendation or prescription in line to -Revised Guidelines on Clinical Management of COVID-19 by Government of India, Ministry of Health & Family Welfare Directorate General of Health Services, (EMR Division), Version 05, 03rd July 2020.. Treatment may include Oral medications like Ivermectin 12mg, once daily, anti-pyretic, anti-tussive multivitamins, and antibiotics 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients willing and able to provide voluntary written informed consent and to follow the protocol requirements.
Male or female patients between 18 and 60 years of age (both inclusive).
Patients with positive RT-PCR test for SARS-CoV-2 in nasopharyngeal or oropharyngeal swabs (sample collected ≤5 days prior to randomization)
Patients with mild COVID-19 (non-hospitalized) and have following symptoms and signs within 3 to 5 days prior to randomization.
Patients having mild COVID-19 with a score of 2 or 3 on the 10-point ordinal scale of clinical status
Patients who are able to consume oral medications.
Males agree to the following during the intervention period and for at least 90 days after the last dose of study intervention:
Females who are not pregnant or breastfeeding
 
 
ExclusionCriteria 
Details  Known hypersensitivity or contraindications to any of the components of the study interventions or to any other similar class of drugs as determined by the investigator.
Uncontrolled comorbid medical conditions.
Patient is currently hospitalized or is expected to need hospitalization for COVID-19 within 48 hours of randomization
Patient is on dialysis or has reduced estimated glomerular filtration rate (eGFR) <30 mL/min/1.73m2 by the Modification of Diet in Renal Disease (MDRD) equation.
If patient has any of the following conditions: human immunodeficiency virus (HIV); chemotherapy required within 6 weeks before randomization; a neutrophilic granulocyte absolute count <500/mm3; autologous or allogeneic hematopoietic stem cell transplant recipient.
If patient has a history of hepatitis B virus (HBV) or hepatitis C virus (HCV) with cirrhosis, end-stage liver disease, hepatocellular carcinoma, aspartate aminotransferase (AST) and/or alanine aminotransferase (ALT) >3X upper limit of normal at screening.
If patient has a platelet count <100,000/μL or received a platelet transfusion in the 5 days prior to randomization.
Patient has a history of acute pancreatitis within 3 months prior to randomization or a history of chronic pancreatitis.
Patient is currently receiving or anticipated to require any prohibited medications/ therapies (e.g. Favipiravir, oseltamivir or any other anti-viral treatments) during study participation as per investigator’s discretion.
A baseline heart rate of < 60 beats per minute at rest
If patient has any condition for which, in the opinion of the investigator, participation would not be in the best interest of the participant or that could prevent, limit, or confound the protocol-specified assessments including but not limited to: participants who are not expected to survive longer than 48 hours after randomization, participants who are expected to require mechanical ventilation within 48 hours after randomization, or participants with a recent history of mechanical ventilation, or participants with conditions that could limit gastrointestinal absorption of capsule contents.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment    
Blinding/Masking    
Primary Outcome  
Outcome  TimePoints 
Rate of hospitalization from randomization up to day 14.  Rate of hospitalization from randomization up to day 14. 
 
Secondary Outcome  
Outcome  TimePoints 
Rate of hospitalization from randomization up to day 28.
Proportion of patients with clinical improvement at the end of treatment day 10 and 14.
Time to clinical improvement from randomization up to day 14.
Mortality rate at day 14.
Mortality rate at day 28.
 
28 days  
 
Target Sample Size   Total Sample Size="1220"
Sample Size from India="1220" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   13/06/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   To evaluate the efficacy of Molnupiravir compared to standard of care in confirmed RT PCR positive patients with mild COVID-19. 
Close